{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T05:03:18Z","timestamp":1788498198876,"version":"build-2803163510"},"reference-count":80,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004329","name":"Javna Agencija za Raziskovalno Dejavnost RS","doi-asserted-by":"publisher","award":["L1-8157"],"award-info":[{"award-number":["L1-8157"]}],"id":[{"id":"10.13039\/501100004329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004329","name":"Javna Agencija za Raziskovalno Dejavnost RS","doi-asserted-by":"publisher","award":["P1-0208"],"award-info":[{"award-number":["P1-0208"]}],"id":[{"id":"10.13039\/501100004329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004442","name":"Narodowym Centrum Nauki","doi-asserted-by":"publisher","award":["UMO-2016\/21\/B\/NZ7\/01744"],"award-info":[{"award-number":["UMO-2016\/21\/B\/NZ7\/01744"]}],"id":[{"id":"10.13039\/501100004442","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000921","name":"European Cooperation in Science and Technology","doi-asserted-by":"publisher","award":["CA15135"],"award-info":[{"award-number":["CA15135"]}],"id":[{"id":"10.13039\/501100000921","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.ejmech.2019.111916","type":"journal-article","created":{"date-parts":[[2019,11,26]],"date-time":"2019-11-26T11:24:38Z","timestamp":1574767478000},"page":"111916","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":56,"special_numbering":"C","title":["1-Benzylpyrrolidine-3-amine-based BuChE inhibitors with anti-aggregating, antioxidant and metal-chelating properties as multifunctional agents against Alzheimer\u2019s disease"],"prefix":"10.1016","volume":"187","author":[{"given":"Tomasz","family":"Wichur","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2549-170X","authenticated-orcid":false,"given":"Anna","family":"Wi\u0119ckowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krzysztof","family":"Wi\u0119ckowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justyna","family":"Gody\u0144","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakub","family":"Jo\u0144czyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1lvaro del R\u00edo","family":"Valdivieso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawid","family":"Panek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Pasieka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raimon","family":"Sabat\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damijan","family":"Knez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9678-3083","authenticated-orcid":false,"given":"Stanislav","family":"Gobec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Malawska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2019.111916_bib1","series-title":"World Alzheimer Report 2016 Improving Healthcare for People Living with Dementia Coverage, QualIty and Costs Now and in the Future","author":"Prince","year":"2016"},{"key":"10.1016\/j.ejmech.2019.111916_bib2","doi-asserted-by":"crossref","first-page":"615","DOI":"10.3233\/JAD-132690","article-title":"Efficacy and safety of donepezil, galantamine, rivastigmine, and memantine for the treatment of Alzheimer\u2019s disease: a systematic review and meta-analysis","volume":"41","author":"Tan","year":"2014","journal-title":"J.\u00a0Alzheimer\u2019s Dis."},{"key":"10.1016\/j.ejmech.2019.111916_bib3","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1159\/000464422","article-title":"Molecular pathogenesis of Alzheimer\u2019s disease: an update","volume":"24","author":"Sanabria-Castro","year":"2017","journal-title":"Ann. Neurosci."},{"key":"10.1016\/j.ejmech.2019.111916_bib4","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/S1471-4914(01)02173-6","article-title":"Evidence of oxidative damage in Alzheimer\u2019s disease brain: central role for amyloid \u03b2-peptide","volume":"7","author":"Butterfield","year":"2001","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.ejmech.2019.111916_bib5","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/S1359-6446(04)03163-0","article-title":"From magic bullets to designed multiple ligands","volume":"9","author":"Morphy","year":"2004","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejmech.2019.111916_bib6","doi-asserted-by":"crossref","first-page":"587","DOI":"10.2174\/138161209787315594","article-title":"Designing multiple ligands - medicinal chemistry strategies and challenges","volume":"15","author":"Morphy","year":"2009","journal-title":"Curr. Pharmaceut. Des."},{"key":"10.1016\/j.ejmech.2019.111916_bib7","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s40169-017-0181-2","article-title":"A\u00a0perspective on multi-target drug discovery and design for complex diseases","volume":"7","author":"Ramsay","year":"2018","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.ejmech.2019.111916_bib8","article-title":"Network analysis of drug-target interactions: a study on FDA-approved new molecular entities between 2000 to 2015","volume":"7","author":"Lin","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2019.111916_bib9","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.ejmech.2019.02.076","article-title":"Advancement of multi-target drug discoveries and promising applications in the field of Alzheimer\u2019s disease","volume":"169","author":"Wang","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111916_bib10","doi-asserted-by":"crossref","first-page":"373","DOI":"10.2174\/0929867321666141106122628","article-title":"Recent development of multifunctional agents as potential drug candidates for the treatment of Alzheimer\u2019s disease","volume":"22","author":"Guzior","year":"2015","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111916_bib11","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.pneurobio.2015.12.003","article-title":"Multitarget compounds bearing tacrine- and donepezil-like structural and functional motifs for the potential treatment of Alzheimer\u2019s disease","volume":"151","author":"Ismaili","year":"2017","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.ejmech.2019.111916_bib12","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1021\/acsmedchemlett.9b00039","article-title":"Harnessing polypharmacology with medicinal chemistry","volume":"10","author":"Bolognesi","year":"2019","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2019.111916_bib13","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/scientificamerican1191-68","article-title":"Amyloid protein and Alzheimer\u2019s disease","volume":"265","author":"Selkoe","year":"1991","journal-title":"Sci. Am."},{"key":"10.1016\/j.ejmech.2019.111916_bib14","doi-asserted-by":"crossref","first-page":"595","DOI":"10.15252\/emmm.201606210","article-title":"The amyloid hypothesis of Alzheimer\u2019s disease at 25 years","volume":"8","author":"Selkoe","year":"2016","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.ejmech.2019.111916_bib15","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1073\/pnas.97.4.1456","article-title":"Human aspartic protease memapsin 2 cleaves the beta-secretase site of beta-amyloid precursor protein","volume":"97","author":"Lin","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ejmech.2019.111916_bib16","first-page":"173","article-title":"Pathological cascade","volume":"34","author":"O\u2019Brien","year":"2011","journal-title":"Arch. Med. Res."},{"key":"10.1016\/j.ejmech.2019.111916_bib17","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.pneurobio.2018.12.006","article-title":"Comprehensive review of mechanisms of pathogenesis involved in Alzheimer\u2019s disease and potential therapeutic strategies","volume":"174","author":"Sharma","year":"2019","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.ejmech.2019.111916_bib18","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.ejmech.2016.02.049","article-title":"Amyloid cascade in Alzheimer\u2019s disease: recent advances in medicinal chemistry","volume":"113","author":"Mohamed","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111916_bib19","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/j.bbadis.2013.10.015","article-title":"Oxidative stress and mitochondrial dysfunction in Alzheimer\u2019s disease","volume":"1842","author":"Wang","year":"2014","journal-title":"Biochim. Biophys. Acta (BBA) - Mol. Basis Dis."},{"key":"10.1016\/j.ejmech.2019.111916_bib20","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-09477-3","article-title":"Different soluble aggregates of A\u03b242 can give rise to cellular toxicity through different mechanisms","volume":"10","author":"De","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2019.111916_bib21","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/j.bbadis.2011.08.005","article-title":"Aging and amyloid beta-induced oxidative DNA damage and mitochondrial dysfunction in Alzheimer\u2019s disease: implications for early intervention and therapeutics","volume":"1812","author":"Mao","year":"2011","journal-title":"Biochim. Biophys. Acta (BBA) - Mol. Basis Dis."},{"key":"10.1016\/j.ejmech.2019.111916_bib22","article-title":"Amyloid-beta interaction with mitochondria","volume":"2011","author":"Eckert","year":"2011","journal-title":"Int. J. Alzheimer\u2019s Dis."},{"key":"10.1016\/j.ejmech.2019.111916_bib23","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1007\/s10072-019-03863-x","article-title":"On the central role of mitochondria dysfunction and oxidative stress in Alzheimer\u2019s disease","volume":"40","author":"Tobore","year":"2019","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.ejmech.2019.111916_bib24","doi-asserted-by":"crossref","first-page":"5193","DOI":"10.1021\/cr300009x","article-title":"Bioinorganic chemistry of Alzheimer\u2019s disease","volume":"112","author":"Kepp","year":"2012","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejmech.2019.111916_bib25","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1039\/B813398K","article-title":"Bioinorganic chemistry of copper and zinc ions coordinated to amyloid-\u03b2 peptide","author":"Faller","year":"2009","journal-title":"Dalton Trans."},{"key":"10.1016\/j.ejmech.2019.111916_bib26","doi-asserted-by":"crossref","first-page":"3191","DOI":"10.1016\/j.bmc.2018.04.043","article-title":"Novel 8-hydroxyquinoline derivatives targeting \u03b2-amyloid aggregation, metal chelation and oxidative stress against Alzheimer\u2019s disease","volume":"26","author":"Yang","year":"2018","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111916_bib27","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1021\/acschemneuro.8b00122","article-title":"Regulatory activities of dopamine and its derivatives toward metal-free and metal-induced amyloid-\u03b2 aggregation, oxidative stress, and inflammation in Alzheimer\u2019s disease","volume":"9","author":"Nam","year":"2018","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ejmech.2019.111916_bib28","doi-asserted-by":"crossref","first-page":"3337","DOI":"10.1002\/anie.200604421","article-title":"Metallo-ROS in Alzheimer\u2019s disease: oxidation of neurotransmitters by CuII-\u03b2-amyloid and neuropathology of the disease","volume":"46","author":"Da Silva","year":"2007","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ejmech.2019.111916_bib29","doi-asserted-by":"crossref","first-page":"12193","DOI":"10.1021\/ic4003059","article-title":"Role of metal ions in the self-assembly of the Alzheimer\u2019s amyloid-beta peptide","volume":"52","author":"Faller","year":"2013","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.ejmech.2019.111916_bib30","doi-asserted-by":"crossref","first-page":"8616","DOI":"10.1021\/acs.jmedchem.5b01222","article-title":"Design, synthesis, and evaluation of orally available clioquinol-moracin M hybrids as multitarget-directed ligands for cognitive improvement in a rat model of neurodegeneration in Alzheimer\u2019s disease","volume":"58","author":"Wang","year":"2015","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111916_bib31","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.ejmech.2019.06.026","article-title":"Design, synthesis, in-silico and biological evaluation of novel chalcone-O-carbamate derivatives as multifunctional agents for the treatment of Alzheimer\u2019s disease","volume":"178","author":"Sang","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111916_bib32","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.ejmech.2019.04.060","article-title":"Multi-targeted ChEI-copper chelating molecules as neuroprotective agents","volume":"174","author":"Sestito","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111916_bib33","doi-asserted-by":"crossref","first-page":"5759","DOI":"10.1016\/j.bmc.2018.08.011","article-title":"Resveratrol-maltol hybrids as multi-target-directed agents for Alzheimer\u2019s disease","volume":"26","author":"Cheng","year":"2018","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111916_bib34","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.ejmech.2018.02.023","article-title":"Novel Tacrine-Hydroxyphenylbenzimidazole hybrids as potential multitarget drug candidates for Alzheimer\u2019s disease","volume":"148","author":"Hiremathad","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111916_bib35","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.tins.2019.03.003","article-title":"A\u00a0unifying hypothesis for Alzheimer\u2019s disease: from plaques to neurodegeneration","volume":"42","author":"Edwards","year":"2019","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.ejmech.2019.111916_bib36","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s40478-016-0339-y","article-title":"Alzheimer\u2019s Disease Neuroimaging Initiative, the relationship between complement factor C3, APOE \u03b54, amyloid and tau in Alzheimer\u2019s disease","volume":"4","author":"Bonham","year":"2016","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.ejmech.2019.111916_bib37","doi-asserted-by":"crossref","first-page":"4135","DOI":"10.1021\/jm3017317","article-title":"Progress and developments in tau aggregation inhibitors for alzheimer disease","volume":"56","author":"Bulic","year":"2013","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111916_bib38","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1001\/jamaneurol.2013.5847","article-title":"Amyloid-\u03b2 and tau: the trigger and bullet in alzheimer disease PathogenesisAmyloid-\u03b2 and TauAmyloid-\u03b2 and tau","volume":"71","author":"Bloom","year":"2014","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.ejmech.2019.111916_bib39","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/nrneurol.2013.223","article-title":"Alzheimer disease therapy\u2014moving from amyloid-\u03b2 to tau","volume":"9","author":"Giacobini","year":"2013","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.ejmech.2019.111916_bib40","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1750-1326-6-39","article-title":"Tau oligomers impair memory and induce synaptic and mitochondrial dysfunction in wild-type mice","volume":"6","author":"Clos","year":"2011","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.ejmech.2019.111916_bib41","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00308809","article-title":"Neuropathological stageing of Alzheimer-related changes","volume":"82","author":"Braak","year":"1991","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.ejmech.2019.111916_bib42","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ejmech.2017.07.070","article-title":"Tau protein aggregation in Alzheimer\u2019s disease: an attractive target for the development of novel therapeutic agents","volume":"139","author":"Jouanne","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111916_bib43","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s40478-019-0664-z","article-title":"A\u00a0walk through tau therapeutic strategies","volume":"7","author":"Jadhav","year":"2019","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.ejmech.2019.111916_bib44","article-title":"A\u00a0review of butyrylcholinesterase as a therapeutic target in the treatment of Alzheimer\u2019s disease","volume":"15","author":"Nordberg","year":"2013","journal-title":"Prim. Care Companion CNS Disord."},{"key":"10.1016\/j.ejmech.2019.111916_bib45","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1002\/gps.935","article-title":"Cholinergic function and Alzheimer\u2019s disease","volume":"18","author":"Giacobini","year":"2003","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.ejmech.2019.111916_bib46","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1093\/ijnp\/pyx012","article-title":"Discontinuation, efficacy, and safety of cholinesterase inhibitors for Alzheimer\u2019s disease: a meta-analysis and meta-regression of 43 randomized clinical trials enrolling 16 106 patients","volume":"20","author":"Blanco-Silvente","year":"2017","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.ejmech.2019.111916_bib47","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.4155\/fmc-2017-0094","article-title":"Advances toward multifunctional cholinesterase and \u03b2-amyloid aggregation inhibitors","volume":"9","author":"Panek","year":"2017","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111916_bib48","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.ejmech.2018.09.031","article-title":"Donepezil-based multi-functional cholinesterase inhibitors for treatment of Alzheimer\u2019s disease","volume":"158","author":"Li","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111916_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2016.09.078","article-title":"Design, synthesis and biological evaluation of new phthalimide and saccharin derivatives with alicyclic amines targeting cholinesterases, beta-secretase and amyloid beta aggregation","volume":"125","author":"Panek","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111916_bib50","doi-asserted-by":"crossref","DOI":"10.1021\/acschemneuro.7b00461","article-title":"Design, synthesis, and biological evaluation of 1-Benzylamino-2-hydroxyalkyl derivatives as new potential disease-modifying multifunctional anti-alzheimer\u2019s agents","volume":"9","author":"Panek","year":"2018","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ejmech.2019.111916_bib51","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1021\/acschemneuro.8b00024","article-title":"Novel multitarget-directed ligands aiming at symptoms and causes of Alzheimer\u2019s disease","volume":"9","author":"Wi\u0119ckowska","year":"2018","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ejmech.2019.111916_bib52","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ejmech.2016.08.016","article-title":"Novel multi-target-directed ligands for Alzheimer\u2019s disease: combining cholinesterase inhibitors and 5-HT6 receptor antagonists. Design, synthesis and biological evaluation","volume":"124","author":"Wi\u0119ckowska","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111916_bib53","doi-asserted-by":"crossref","DOI":"10.3390\/molecules23020347","article-title":"Design, synthesis, and biological evaluation of 2-(benzylamino-2-Hydroxyalkyl)Isoindoline-1,3-diones derivatives as potential disease-modifying multifunctional anti-alzheimer agents","volume":"23","author":"Panek","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2019.111916_bib54","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/0006-2952(61)90145-9","article-title":"A\u00a0new and rapid colorimetric determination of acetylcholinesterase activity","volume":"7","author":"Ellman","year":"1961","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2019.111916_bib55","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1126\/science.286.5440.735","article-title":"Beta-secretase cleavage of Alzheimer\u2019s amyloid precursor protein by the transmembrane aspartic protease BACE","volume":"286","author":"Vassar","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2019.111916_bib56","doi-asserted-by":"crossref","first-page":"6447","DOI":"10.1021\/jm049379g","article-title":"Structure-based design of potent and selective cell-permeable inhibitors of human beta-secretase (BACE-1)","volume":"47","author":"Stachel","year":"2004","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111916_bib57","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1002\/pro.5560020312","article-title":"Thioflavine T interaction with synthetic Alzheimer\u2019s disease beta-amyloid peptides: detection of amyloid aggregation in solution","volume":"2","author":"LeVine","year":"1993","journal-title":"Protein Sci."},{"key":"10.1016\/j.ejmech.2019.111916_bib58","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/srep23349","article-title":"Ultra rapid in\u00a0vivo screening for anti-Alzheimer anti-amyloid drugs","volume":"6","author":"Espargar\u00f3","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2019.111916_bib59","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1007\/s00018-010-0344-4","article-title":"Protein folding and aggregation in bacteria","volume":"67","author":"Sabate","year":"2010","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.ejmech.2019.111916_bib60","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1111\/j.1742-4658.2011.08165.x","article-title":"Biological role of bacterial inclusion bodies: a model for amyloid aggregation","volume":"278","author":"Garc\u00eda-Fruit\u00f5s","year":"2011","journal-title":"FEBS J."},{"key":"10.1016\/j.ejmech.2019.111916_bib61","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1021\/acs.jnatprod.6b00643","article-title":"Combined in\u00a0vitro cell-based\/in silico screening of naturally occurring flavonoids and phenolic compounds as potential anti-alzheimer drugs","volume":"80","author":"Espargar\u00f3","year":"2017","journal-title":"J.\u00a0Nat. Prod."},{"key":"10.1016\/j.ejmech.2019.111916_bib62","doi-asserted-by":"crossref","first-page":"4858","DOI":"10.1002\/anie.200806100","article-title":"Solid-state NMR spectroscopy reveals that E. coli inclusion bodies of HET-s(218\u2013289) are amyloids","volume":"48","author":"Wasmer","year":"2009","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ejmech.2019.111916_bib63","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/1475-2859-11-89","article-title":"Yeast prions form infectious amyloid inclusion bodies in bacteria","volume":"11","author":"Espargar\u00f3","year":"2012","journal-title":"Microb. Cell Factories"},{"key":"10.1016\/j.ejmech.2019.111916_bib64","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/cbic.201000602","article-title":"Bacterial inclusion bodies of Alzheimer\u2019s disease \u03b2-amyloid peptides can Be employed to study native-like aggregation intermediate states","volume":"12","author":"Dasari","year":"2011","journal-title":"Chembiochem"},{"key":"10.1016\/j.ejmech.2019.111916_bib65","doi-asserted-by":"crossref","first-page":"4693","DOI":"10.1016\/j.bmc.2018.08.007","article-title":"Synthesis and evaluation of 1,2,3,4-tetrahydro-1-acridone analogues as potential dual inhibitors for amyloid-beta and tau aggregation","volume":"26","author":"Lv","year":"2018","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111916_bib66","series-title":"A.I.B.T.-B","first-page":"1","article-title":"Chapter 1 - biometals and Alzheimer\u2019s disease","author":"Mot","year":"2017"},{"key":"10.1016\/j.ejmech.2019.111916_bib67","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0022-510X(98)00092-6","article-title":"Copper, iron and zinc in Alzheimer\u2019s disease senile plaques","volume":"158","author":"Lovell","year":"1998","journal-title":"J.\u00a0Neurol. Sci."},{"key":"10.1016\/j.ejmech.2019.111916_bib68","doi-asserted-by":"crossref","first-page":"4248","DOI":"10.1074\/jbc.M110.158980","article-title":"Iron promotes the toxicity of amyloid \u03b2 peptide by impeding its ordered aggregation","volume":"286","author":"Liu","year":"2011","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2019.111916_bib69","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.archger.2014.04.002","article-title":"Age-related iron deposition in the basal ganglia of controls and Alzheimer disease patients quantified using susceptibility weighted imaging","volume":"59","author":"Wang","year":"2014","journal-title":"Arch. Gerontol. Geriatr."},{"key":"10.1016\/j.ejmech.2019.111916_bib70","doi-asserted-by":"crossref","first-page":"737","DOI":"10.3233\/JAD-151037","article-title":"Patterns of brain iron accumulation in vascular dementia and Alzheimer\u2019s dementia using quantitative susceptibility mapping imaging","volume":"51","author":"Moon","year":"2016","journal-title":"J.\u00a0Alzheimer\u2019s Dis."},{"key":"10.1016\/j.ejmech.2019.111916_bib71","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/978-3-319-60189-2_10","article-title":"Copper and Alzheimer\u2019s disease","volume":"18","author":"Mathys","year":"2017","journal-title":"Adv. Neurobiol."},{"key":"10.1016\/j.ejmech.2019.111916_bib72","doi-asserted-by":"crossref","first-page":"7916","DOI":"10.1039\/C8SC04041A","article-title":"Cu(2+) selective chelators relieve copper-induced oxidative stress in\u00a0vivo","volume":"9","author":"Rakshit","year":"2018","journal-title":"Chem. Sci."},{"key":"10.1016\/j.ejmech.2019.111916_bib73","doi-asserted-by":"crossref","first-page":"6727","DOI":"10.1039\/C4CS00138A","article-title":"Biological metals and metal-targeting compounds in major neurodegenerative diseases","volume":"43","author":"Barnham","year":"2014","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.ejmech.2019.111916_bib74","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1002\/cbic.201402718","article-title":"Tools of the trade: investigations into design strategies of small molecules to target components in Alzheimer\u2019s disease","volume":"16","author":"Derrick","year":"2015","journal-title":"Chembiochem"},{"key":"10.1016\/j.ejmech.2019.111916_bib75","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.pnpbp.2004.05.023","article-title":"Role of oxidative stress in neurodegeneration: recent developments in assay methods for oxidative stress and nutraceutical antioxidants","volume":"28","author":"Cui","year":"2004","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.ejmech.2019.111916_bib76","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1021\/jf048396b","article-title":"Rapid determination of polyphenols and vitamin C in plant-derived products","volume":"53","author":"Georg\u00e9","year":"2005","journal-title":"J.\u00a0Agric. Food Chem."},{"key":"10.1016\/j.ejmech.2019.111916_bib77","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1006\/abio.1996.0292","article-title":"The ferric reducing ability of Plasma (FRAP) as a measure of \u201cantioxidant power\u201d: the FRAP assay","volume":"239","author":"Benzie","year":"1996","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.ejmech.2019.111916_bib78","doi-asserted-by":"crossref","first-page":"5608","DOI":"10.3390\/ijms14035608","article-title":"Structure-based search for new inhibitors of cholinesterases","volume":"14","author":"Bajda","year":"2013","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2019.111916_bib79","doi-asserted-by":"crossref","first-page":"5128","DOI":"10.3390\/ijms15035128","article-title":"Application of computational methods for the design of BACE-1 inhibitors: validation of in silico modelling","volume":"15","author":"Bajda","year":"2014","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2019.111916_bib80","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.2174\/09298673113206660256","article-title":"Thioflavin-S staining of bacterial inclusion bodies for the fast, simple, and inexpensive screening of amyloid aggregation inhibitors","volume":"21","author":"D.M.-T.","year":"2014","journal-title":"Curr. Med. Chem."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523419310682?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523419310682?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:02:02Z","timestamp":1759327322000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523419310682"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":80,"alternative-id":["S0223523419310682"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2019.111916","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"1-Benzylpyrrolidine-3-amine-based BuChE inhibitors with anti-aggregating, antioxidant and metal-chelating properties as multifunctional agents against Alzheimer\u2019s disease","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2019.111916","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"111916"}}